Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Insmed, Inc.

Insmed, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. They are focused on the development and commercialization of novel, targeted inhaled therapies for patients with high unmet need battling orphan lung diseases.

Search Projects

  • Senior Director Clinical Operations
  • Senior Director Program Management